company background image
CVS logo

CVS Health NYSE:CVS Stock Report

Last Price

US$65.23

Market Cap

US$83.6b

7D

0.5%

1Y

-14.1%

Updated

10 Mar, 2025

Data

Company Financials +

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

US$72.46
FV
10.0% undervalued intrinsic discount
5.16%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
70users have followed this narrative
Updated narrative
US$103.00
FV
36.7% undervalued intrinsic discount
18.02%
Revenue growth p.a.
13users have liked this narrative
0users have commented on this narrative
96users have followed this narrative
4 months ago author updated this narrative

My Notes

Capture your thoughts, links and company narrative

CVS Health Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for CVS Health
Historical stock prices
Current Share PriceUS$65.23
52 Week HighUS$80.75
52 Week LowUS$43.56
Beta0.53
1 Month Change20.77%
3 Month Change18.28%
1 Year Change-14.10%
3 Year Change-37.57%
5 Year Change24.72%
Change since IPO9,835.69%

Recent News & Updates

Is CVS Health (NYSE:CVS) A Risky Investment?

Mar 07
Is CVS Health (NYSE:CVS) A Risky Investment?

CVS Health: Incremental Improvement Best Hope For 2025 (Rating Downgrade)

Feb 26

Market Might Still Lack Some Conviction On CVS Health Corporation (NYSE:CVS) Even After 25% Share Price Boost

Feb 17
Market Might Still Lack Some Conviction On CVS Health Corporation (NYSE:CVS) Even After 25% Share Price Boost

Recent updates

Is CVS Health (NYSE:CVS) A Risky Investment?

Mar 07
Is CVS Health (NYSE:CVS) A Risky Investment?

CVS Health: Incremental Improvement Best Hope For 2025 (Rating Downgrade)

Feb 26

Market Might Still Lack Some Conviction On CVS Health Corporation (NYSE:CVS) Even After 25% Share Price Boost

Feb 17
Market Might Still Lack Some Conviction On CVS Health Corporation (NYSE:CVS) Even After 25% Share Price Boost

Earnings Beat: CVS Health Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 14
Earnings Beat: CVS Health Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold

Feb 13

CVS Health Isn't Going To The Dogs

Jan 17

CVS Health: An Attractive 5.8% Safe Yield For Now

Jan 10

Market Cool On CVS Health Corporation's (NYSE:CVS) Earnings Pushing Shares 25% Lower

Dec 26
Market Cool On CVS Health Corporation's (NYSE:CVS) Earnings Pushing Shares 25% Lower

CVS Health: When The Industry Is In Crisis, Don't Pick The Weaker Players

Dec 10

There May Be Some Bright Spots In CVS Health's (NYSE:CVS) Earnings

Nov 19
There May Be Some Bright Spots In CVS Health's (NYSE:CVS) Earnings

CVS Health: Cheap But No Signs Of Turnaround (Yet)

Nov 06

CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet

Nov 03
CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet

CVS Health Stock Dip: Undervalued And Ready For A Turnaround

Oct 24

CVS Health: Glenview's Activism Ramps Up Pressure On Management

Sep 30

CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)

Sep 10

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Jul 21
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

CVS Health: A Better Investment Than Walgreens Boots Alliance

Jul 09

Vltava Fund - CVS Health Corp.: Why We Sold CVS

Jul 03

CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell

Jun 21

The Correct Play On CVS Health

Jun 06

CVS Health: Downside Movement Is Overdramatic

May 26

CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

May 15

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

CVS Health: A Terrible Earnings Report, But An Undervalued Stock

May 04

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Shareholder Returns

CVSUS HealthcareUS Market
7D0.5%3.3%-1.7%
1Y-14.1%-4.4%12.1%

Return vs Industry: CVS underperformed the US Healthcare industry which returned -4.4% over the past year.

Return vs Market: CVS underperformed the US Market which returned 12.1% over the past year.

Price Volatility

Is CVS's price volatile compared to industry and market?
CVS volatility
CVS Average Weekly Movement6.9%
Healthcare Industry Average Movement7.2%
Market Average Movement6.3%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.3%

Stable Share Price: CVS has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CVS's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996259,500J. Joynerwww.cvshealth.com

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services.

CVS Health Corporation Fundamentals Summary

How do CVS Health's earnings and revenue compare to its market cap?
CVS fundamental statistics
Market capUS$83.63b
Earnings (TTM)US$4.61b
Revenue (TTM)US$370.66b

17.8x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVS income statement (TTM)
RevenueUS$370.66b
Cost of RevenueUS$321.41b
Gross ProfitUS$49.25b
Other ExpensesUS$44.63b
EarningsUS$4.61b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)3.66
Gross Margin13.29%
Net Profit Margin1.24%
Debt/Equity Ratio85.7%

How did CVS perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

73%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/10 23:01
End of Day Share Price 2025/03/10 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CVS Health Corporation is covered by 60 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harshit GuptaAccountability Research Corporation
Christopher GrajaArgus Research Company
Samuel HudsonAtlantic Equities LLP